Mr
Douglas
Drysdale

Partner & Patent Attorney

Glasgow Office

Life sciences

Telephone. +44(0) 141 229 5800
Mobile. +44(0) 783 322 8216
Email. [email protected]

Experience

Douglas specialises in global patent strategy, filing and prosecution, advising a wide range of clients on how to build and maximise the value of their IP estate. He is also extremely experienced in patent opposition and appeals, regularly representing his clients in high profile hearings at the EPO. Douglas and his team represent leading biotech and life science companies, as well as several universities. His clients appreciate his desire to understand both their business and their technology.

Specialisms

  • Agbio
  • Bioprocessing
  • Cell and gene therapy
  • Diagnostics
  • Food technology
  • Gene editing technologies
  • Personalised medicine

Industries

  • Food & drink icon Food & drink
  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Due diligence
  • Patent oppositions & appeals
  • Patents
  • Portfolio management
  • Searching & competitor monitoring
  • Strategy
  • Transactional IP & commercial support

Qualifications

Patent Attorney

Chartered (UK)
European


BSC

Molecular Biology - 1st Class Honours

MSC

MSc - Management of IP Law - Queen Mary's University of London

Publications

IAM Strategy 300 2021

View publication online

G1/21 hearing at the EPO

View publication online

T0694/16 - New EPO Technical Board of Appeal decision regarding personalised healthcare inventions

View publication online

Conferences: 2021

July 2nd 2021

G1/21 hearing at the EPO - July

Attended

Event details

Conferences: 2020

January 28th 2020

IAM Pharma & Biotech IP Summit 2020 - London

Speaker

Event details

Related News

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Getting your first filing right

One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …

Read article

Tarilian Laser Technologies - a case study in due diligence

When deciding whether to invest in a company, an investor will inevitably have to decide the value of the company. Taking a simplified view, a company’s valuation can be considered …

Read article

Health-conscious IP strategies

Strategies for navigating European patent portfolios in healthcare. Securing patent protection is critically important for innovative companies operating in the healthcare sector. European patent filings in healthcare, and particularly those …

Read article

Start-ups & IP, a case study: SleepCogni

Using SleepCogni as a case study, we look at some key ways that IP can help start-ups to develop their technology and secure investment. SleepCogni is a SleepTech start-up who …

Read article
Event - 9th December 2021

Technology Transfer Primer - IP Management: AI and 5G in healthcare

The University of Hong Kong is hosting a webinar on ‘IP Management: AI and 5G in healthcare’ on 9th December 2021 with HGF’s Partner Dr Chris Benson and Patent Director …

Event details
Event - 1st December 2021

Webinar: Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan

Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips …

Event details

Brand protection on e-commerce platforms

HGF recently presented on this topic at the Luxury Law Summit conference in London, which emphasised the need for brands to take a robust strategy to trade mark protection online. …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.